EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Botulinum Toxin and Deep Brain Stimulation in Dystonia

Julia Carvalhinho Carlos de Souza, Ananda Carolina Moraes Falcone, Renata Montes Garcia Barbosa iD, Miriam Carvalho Soares iD, Renato Munhoz, Marina Farah, Tamine Capato iD, Sara Carvalho Barbosa Casagrande, Marcela Ferreira Cordellini iD, Gabriel de Castro Micheli, João Carlos Papaterra Limongi, Egberto Reis Barbosa und 2 weitere

Toxins · 2024

DOI: 10.3390/toxins16060282 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Toxins, 2024. Verfasst von Julia Carvalhinho Carlos de Souza und 13 weiteren Autor:innen. Beteiligte Einrichtung: Movement Disorders Center, Department of Neurology, School of Medicine, University of São Paulo, São Paulo 05403-000, Brazil. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Dystonia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deep Brain Stimulation (DBS) is a recognized treatment for different dystonia subtypes and has been approved by the Food and Drug Administration (FDA) since 2003. The European Federation of Neurological Societies (EFNS) and the International Parkinson and Movement Disorders Society (MDS) recommend DBS for dystonia after failure of botulinum toxin (BoNT) and other oral medications for dystonia treatment. In addition, several long-term studies have demonstrated the continuous efficacy of DBS on motor and quality of life (QoL) scores. However, there are only a few reports comparing the overall impact of surgical treatment in BoNT protocols (e.g., dosage and number of selected muscles before and after surgery). This retrospective multicenter chart-review study analyzed botulinum toxin total dosage and dosage per muscle in 23 dystonic patients before and after DBS surgery. The study’s primary outcome was to analyze whether there was a reduction in BoNT dosage after DBS surgery. The mean BoNT dosages difference between baseline and post-surgery was 293.4 units for 6 months, 292.6 units for 12 months, and 295.2 units at the last visit. The median total dose of BoNT in the preoperative period was 800 units (N = 23). At the last visit, the median was 700 units (p = 0.05). This represents a 12.5% reduction in BoNT median dosage. In conclusion, despite the limitations of this retrospective study, there was a significant reduction in BoNT doses after DBS surgery in patients with generalized dystonia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep Brain StimulationDystoniaHumansRetrospective StudiesMaleFemaleMiddle AgedAdultBotulinum ToxinsAgedTreatment OutcomeQuality of Life

Stichwörter der Autor:innen

Deep Brain Stimulationabobotulinum toxinAbotulinum toxindystoniaonabotulinum toxinA

Substanzen

Botulinum Toxins

Autor:innen und Institutionen

  • Movement Disorders Center, Department of Neurology, School of Medicine, University of São Paulo, São Paulo 05403-000, Brazil.
  • Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, University Health Network, Toronto, ON M5T 2S8, Canada.
  • Cajuru University Hospital, Pontíficia Universidade Católica do Paraná, Curitiba 80050-350, Brazil.
  • Department of Neurology, Radboud University Medical Center, 6525 Nijmegen, The Netherlands.
  • Instituto de Neurologia de Curitiba, Curitiba 81210-310, Brazil.
  • Department of Neurology, University Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro, Rio de Janeiro 21941-617, Brazil.

ORCID-Profile: Renata Montes Garcia Barbosa, Miriam Carvalho Soares, Tamine Capato, Marcela Ferreira Cordellini

Zitieren

APA

de Souza, J. C. C., Falcone, A. C. M., Barbosa, R. M. G., Soares, M. C., Munhoz, R., Farah, M., Capato, T., Casagrande, S. C. B., Cordellini, M. F., de Castro Micheli, G., Limongi, J. C. P., Barbosa, E. R., Listik, C., & Cury, R. G. (2024). Botulinum Toxin and Deep Brain Stimulation in Dystonia. Toxins. https://doi.org/10.3390/toxins16060282

Vancouver

de Souza JCC, Falcone ACM, Barbosa RMG, Soares MC, Munhoz R, Farah M, et al. Botulinum Toxin and Deep Brain Stimulation in Dystonia. Toxins. 2024. doi:10.3390/toxins16060282

BibTeX
@article{deSouza2024,
  author = {de Souza, Julia Carvalhinho Carlos and Falcone, Ananda Carolina Moraes and Barbosa, Renata Montes Garcia and Soares, Miriam Carvalho and Munhoz, Renato and Farah, Marina and Capato, Tamine and Casagrande, Sara Carvalho Barbosa and Cordellini, Marcela Ferreira and de Castro Micheli, Gabriel and Limongi, João Carlos Papaterra and Barbosa, Egberto Reis and Listik, Clarice and Cury, Rubens Gisbert},
  title = {Botulinum Toxin and Deep Brain Stimulation in Dystonia},
  journal = {Toxins},
  year = {2024},
  doi = {10.3390/toxins16060282}
}
Kostenlos starten →